These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thin filament proteins mutations associated with skeletal myopathies: defective regulation of muscle contraction. Ochala J J Mol Med (Berl); 2008 Nov; 86(11):1197-204. PubMed ID: 18574571 [TBL] [Abstract][Full Text] [Related]
3. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies. Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096 [TBL] [Abstract][Full Text] [Related]
4. Congenital myopathies: diseases of the actin cytoskeleton. Clarkson E; Costa CF; Machesky LM J Pathol; 2004 Nov; 204(4):407-17. PubMed ID: 15495263 [TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle disease due to mutations in tropomyosin, troponin and cofilin. Clarke NF Adv Exp Med Biol; 2008; 642():40-54. PubMed ID: 19181092 [TBL] [Abstract][Full Text] [Related]
6. The Primary Causes of Muscle Dysfunction Associated with the Point Mutations in Tpm3.12; Conformational Analysis of Mutant Proteins as a Tool for Classification of Myopathies. Borovikov YS; Karpicheva OE; Simonyan AO; Avrova SV; Rogozovets EA; Sirenko VV; Redwood CS Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544720 [TBL] [Abstract][Full Text] [Related]
7. [Congenital myopathies - skeletal muscle diseases related to disorder of actin filament structure and functions]. Robaszkiewicz K; Moraczewska J Postepy Hig Med Dosw (Online); 2011 Jun; 65():347-56. PubMed ID: 21677359 [TBL] [Abstract][Full Text] [Related]
9. Demonstration of beta-tropomyosin (Tpm2) and duplication of the alpha-slow tropomyosin gene (TPM3) in Atlantic salmon Salmo salar. Silva AMM; Kennedy LS; Hasan SC; Cohen AM; Heeley DH Comp Biochem Physiol B Biochem Mol Biol; 2020 Jul; 245():110439. PubMed ID: 32283206 [TBL] [Abstract][Full Text] [Related]
10. An alphaTropomyosin mutation alters dimer preference in nemaline myopathy. Corbett MA; Akkari PA; Domazetovska A; Cooper ST; North KN; Laing NG; Gunning PW; Hardeman EC Ann Neurol; 2005 Jan; 57(1):42-9. PubMed ID: 15562513 [TBL] [Abstract][Full Text] [Related]
11. Nebulin interactions with actin and tropomyosin are altered by disease-causing mutations. Marttila M; Hanif M; Lemola E; Nowak KJ; Laitila J; Grönholm M; Wallgren-Pettersson C; Pelin K Skelet Muscle; 2014; 4():15. PubMed ID: 25110572 [TBL] [Abstract][Full Text] [Related]
12. Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patients. Marston S; Memo M; Messer A; Papadaki M; Nowak K; McNamara E; Ong R; El-Mezgueldi M; Li X; Lehman W Hum Mol Genet; 2013 Dec; 22(24):4978-87. PubMed ID: 23886664 [TBL] [Abstract][Full Text] [Related]
13. Myopathy-causing Q147P TPM2 mutation shifts tropomyosin strands further towards the open position and increases the proportion of strong-binding cross-bridges during the ATPase cycle. Karpicheva OE; Simonyan AO; Kuleva NV; Redwood CS; Borovikov YS Biochim Biophys Acta; 2016 Mar; 1864(3):260-267. PubMed ID: 26708479 [TBL] [Abstract][Full Text] [Related]
14. Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy. Akkari PA; Song Y; Hitchcock-DeGregori S; Blechynden L; Laing N Biochem Biophys Res Commun; 2002 Aug; 296(2):300-4. PubMed ID: 12163017 [TBL] [Abstract][Full Text] [Related]
15. Variants in tropomyosins TPM2 and TPM3 causing muscle hypertonia. Wallgren-Pettersson C; Jokela M; Lehtokari VL; Tyynismaa H; Sainio MT; Ylikallio E; Tynninen O; Pelin K; Auranen M Neuromuscul Disord; 2024 Feb; 35():29-32. PubMed ID: 38219297 [TBL] [Abstract][Full Text] [Related]
16. Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy. Citirak G; Witting N; Duno M; Werlauff U; Petri H; Vissing J Neuromuscul Disord; 2014 Apr; 24(4):325-30. PubMed ID: 24507666 [TBL] [Abstract][Full Text] [Related]
17. Tropomyosin isoforms differentially modulate the regulation of actin filament polymerization and depolymerization by cofilins. Robaszkiewicz K; Ostrowska Z; Marchlewicz K; Moraczewska J FEBS J; 2016 Feb; 283(4):723-37. PubMed ID: 26663234 [TBL] [Abstract][Full Text] [Related]
18. Mutations Q93H and E97K in Śliwinska M; Robaszkiewicz K; Wasąg P; Moraczewska J Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919826 [TBL] [Abstract][Full Text] [Related]
19. Cap disease due to mutation of the beta-tropomyosin gene (TPM2). Clarke NF; Domazetovska A; Waddell L; Kornberg A; McLean C; North KN Neuromuscul Disord; 2009 May; 19(5):348-51. PubMed ID: 19345583 [TBL] [Abstract][Full Text] [Related]